Aptamer Group (APTA) Share Price

Health Care Sector


NOTE: This is based on 29 open tips for Aptamer Group (APTA)


Aptamer Group (APTA)
Latest Quote Price

0.65p

Aptamer Group (APTA)
Price Change (%)

-11.69%


Latest Bid : 0.60p Latest Ask : 0.70p
High Today : 0.75p Low Today : 0.62p
This Years High : 1.30p This Years Low : 0.24p
Volume : 4,685,405 MKT Cap : £12.48M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Aptamer Group (APTA) Overview

Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.

Aptamer Group (APTA) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2026-02-17 16:35:00 17/02/2026 27.78%
Sell Steve Moore Premium Only 2025-12-23 16:30:00 23/12/2025 27.78%
Sell Steve Moore Premium Only 2025-11-28 08:05:00 28/11/2025 18.75%
Sell Steve Moore Premium Only 2025-11-14 16:05:00 14/11/2025 27.78%
Avoid Steve Moore Premium Only 2025-10-14 13:40:00 14/10/2025 23.53%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Aptamer Group (APTA) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.60p Latest Ask : 0.70p
High Today : 0.75p Low Today : 0.62p
This Years High : 1.30p This Years Low : 0.24p
Volume : 4,685,405 MKT Cap : £12.48M

Aptamer Group Overview

Aptamer Group operates within the life sciences sector and is a leader in the provision of aptamer discovery and selection services and in developing aptamer-based reagents. The Company operates across three life science sectors: custom services (research and bioprocessing tools), diagnostics and therapeutics. The Company strives to deliver transformational solutions that meet the needs of developers and users of diagnostic platforms, scientific researchers and companies involved in drug development and manufacturing.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Aptamer Group Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2026-02-17 16:35:00 17/02/2026 27.78%
Sell Steve Moore Premium Only 2025-12-23 16:30:00 23/12/2025 27.78%
Sell Steve Moore Premium Only 2025-11-28 08:05:00 28/11/2025 18.75%
Sell Steve Moore Premium Only 2025-11-14 16:05:00 14/11/2025 27.78%
Avoid Steve Moore Premium Only 2025-10-14 13:40:00 14/10/2025 23.53%